Curious about how #AI is shaping the future of drug discovery? Don’t miss our CEO Michael Nally’s interview with Brad Loncar on BiotechTV at the AI x Bio Summit at the NYSE.
Mike shares exciting updates on our clinical programs, including our COVID-19 antibody and anti-TSLP molecule. Discover how we’re leveraging AI to build de novo proteins and reach historically undruggable targets. “By programming biology, we’re transforming drug discovery and creating better medicines faster." Learn more about the future of biotech in this compelling conversation.
Check out the full interview:
https://lnkd.in/gPFP2yEK#ProteinEngineering | #GenerativeAI
In 2024, women make up only 28.2% of the STEM workforce, with their representation in leadership roles even more staggering, with just 11% holding C-suite positions. These insights, from the 2024 Global Gender Gap Report by the World Economic Forum, highlight the crucial need for mentorship and support in advancing women’s careers. Leaders like our Chief Technical Operations Officer, Lisa Wyman, are essential in driving this change.
Leadership isn’t just a title; it’s a journey. Lisa emphasizes the importance of authentic leadership, where nurturing potential and fostering innovation take center stage. She highlights the essential skills like conflict resolution, delegation, driving team results, and collaboration.
Lisa's commitment to leadership and mentorship inspire us all. What qualities do you believe define a great leader?
#WomenInSTEM | #FiercelyUnited | #TeamGenerate
Biotech Executive I CMC Operations & AI Drug Development | Board Leadership & Value Creation
In the biotech industry, where innovation moves at lightning speed, understanding what makes a great leader is crucial. I’m often asked for mentorship and career advice, which has led me to reflect deeply on what it takes to be an effective leader. This reflection has shaped my approach and reinforced my commitment to nurturing leadership potential in others.
Choosing to Lead
True leadership should come naturally, not be forced. I’ve had the privilege of working with some incredible minds who excel when they can direct their own careers toward what they love and do best. Witnessing the innovation and satisfaction that arise from this freedom is inspiring.
Developing and Mentoring Leaders
Leadership is more than just a title; it's a journey. When mentoring, I dive into tough conversations and focus on essential skills like conflict resolution, delegation, and driving team results. It’s all about collaborating effectively to fully realize our collective potential.
Looking Inward
The best leaders I know are continually in tune with their inner selves. Effective leadership involves understanding your strengths and weaknesses and using that knowledge to lead with empathy and insight. I consistently strive to learn more about myself, which enhances my ability to connect with my team and guide them more effectively.
True leadership is crafted with care and shared wisdom. I’d love to hear from you. What do you think makes a great leader? #Leadership#Biotech#Mentorship
Scientific discovery doesn’t happen in a silo. It requires industry-wide collaboration, bringing the brightest minds together around the latest technology that’s shaping the future of drug discovery and development.
With this spirit of partnership in mind, we were honored to welcome Dan Shine, Senior Vice President and President of the Analytical Instrument Group at Thermo Fisher Scientific, to our #CryoEM lab in Andover, Massachusetts. Alongside Claudio Morales Perez, Patricia Feliciano, Edward Brignole, and Adam Root, the day featured a tour of our facility.
Want to join our cutting-edge CryoEM team? We’re currently seeking a Software Engineer III, Computational Structure Determination. Learn more here: https://lnkd.in/eJbVHqXb#UnapologeticallyScientific | #GenerativeAI
What does it take to build an AI-driven biotech in 2024? Our CEO Michael Nally will share his insight into this very topic as part of a panel discussion at Decoding Bio’s second annual AI x Bio Summit at the NYSE on July 25.
Convening industry leaders working at the intersection of computation and life sciences, this panel will explore company building strategies, emerging technologies, stakeholder engagement, and more.
Mike will be joined by panelists Nabiha Saklayen of Cellino and Sajith Wickramasekara of Benchling, with Bigyan Bista of Enveda Biosciences moderating the discussion.
#GenerativeAI | #UnapologeticallyScientific
What can’t AI do? Kyle LaHucik at Endpoints News sets out to answer this by exploring how #AI is revolutionizing biotech with insights from Noubar Afeyan, CEO and founder of Flagship Pioneering and our chairman and co-founder.
“Multiple Flagship companies are doing work in AI, most notably with Generate:Biomedicines, which has raised more than $700 million to create new proteins using artificial intelligence. It has a broad pipeline across immunology, infectious disease, and oncology,” Afeyan highlighted.
#TeamGenerate is harnessing AI to program biology, transforming how medicines are created. Together, we’re targeting humanity’s most intractable diseases with unprecedented precision and speed.
Discover more about how AI is driving the future of biotech. https://lnkd.in/dx759Vt9#GenerativeBiology | #NowWeCan | #FlagshipFounded
I spoke with Flagship Pioneering CEO Noubar Afeyan about the new $3.6 billion pool of capital that the life sciences incubator and investor has to deploy into about 25 companies.
We spoke about tackling uncertainties (and can that model be viewed through an efficiency lens?), machine learning's spread, creating the "next-next' iteration of ADCs and radiopharmaceuticals, and more.
“The field is dividing up into almost two buckets: people who make bets on very late-stage assets, either as the basis of a startup, knowing that if something hits, then the pharma companies may buy them or the public market would be interested in them,” he told Endpoints News. “Then [there’s the] people who have the resources and the patience to be able to develop entirely new capabilities and see them through, which involves a lot of financing and a lot of partnering.”
#flagshippioneering#venturecapital#biotech#lifesciences#incubator#pharma#drugdevelopment
Inspiring developments today from Flagship Pioneering with a $3.6 billion raise to drive groundbreaking innovations in health and sustainability. As part of the #FlagshipFounded ecosystem, we are pushing the boundaries of science to create a better future, together.
On Bloomberg Television with Francine Lacqua, Noubar Afeyan, CEO and founder of Flagship Pioneering and our own chairman and co-founder, spoke about this new funding and its transformative potential. He highlighted our innovative approach, saying, “We can now computationally generate programmable antibodies to target any disease with unprecedented speed and precision.”
Catch the full discussion to learn how we’re programming the future of medicine: https://lnkd.in/egcEgNrR#GenerativeAI | #ProteinEngineering | #NowWeCan
On July 11, our EVP and Head of Research and Development, Alexandra Snyder, MD, will be speaking at the "Oncology AI/ML - Proven Impact" panel during Leerink Partners AI/ML in Healthcare: Transformation or Evolution conference.
As an oncologist who has witnessed the urgent need for better cancer treatments, Alex will discuss how leveraging technology and data allows us to craft therapies that target cancers at their core, offering new hope where traditional methods have fallen short. She will illustrate our commitment to delivering breakthrough therapies to patients who can't wait.
Joining industry leaders Karim Beguir of InstaDeep, Ryan Richardson of BioNTech SE, and Iker Huerga of Tempus AI, with moderation by Daina Graybosch of Leerink Partners, Alex will provide insights on how these innovations are shaping the future of oncology.
#PatientFirst | #GenerativeBiology
Our Computational Sciences team recently spent an exciting day at Fenway Park, enjoying a Boston Red Sox game together. This shared experience underscores the camaraderie and collaborative spirit that drive our groundbreaking innovations.
Ready to push the boundaries of drug discovery with a team that’s redefining what’s possible? Apply now to join us as a Machine Learning Scientist and contribute to our mission of creating novel therapeutics at the intersection of computation and biology.
Apply here: https://lnkd.in/gKaKkEGJ#GenerativeBiology | #UnapologeticallyScientific
Every Summer, #TeamGenerate takes a well-deserved week off over the Fourth of July to rest and recharge for what’s next. This break allows us to return with renewed energy and a fresh perspective, ready to continue pushing the boundaries of what’s possible.
Accordingly, we will be closed next week and will be back on Monday, July 8. As one #FiercelyUnited organization, we’re looking forward to continuing to advance our vision of instantly generating optimal therapeutics for the greatest impact on human health.
#AudaciouslyAmbitious I #UnapologeticallyScientific